(Q45827796)

16 December 2017

title

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype (English)

1 reference

16 December 2017

0 references

vaccinia virus

1 reference

1 reference

5

Moss B

1 reference

16 December 2017

Geoffrey Lilley Smith

2

object named as

Smith GL

1 reference

16 December 2017

author name string

Buller RM

1

1 reference

16 December 2017

Cremer K

3

1 reference

16 December 2017

Notkins AL

4

1 reference

16 December 2017

publication date

1 October 1985

1 reference

16 December 2017

language of work or name

0 references

1 reference

16 December 2017

volume

317

1 reference

16 December 2017

issue

6040

1 reference

16 December 2017

page(s)

813-815

1 reference

16 December 2017

Physical mapping of herpes simplex virus type 1 mutations by marker rescue

cites work

1 reference

7 January 2021

A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

1 reference

7 January 2021

Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA

1 reference

7 January 2021

Molecular genetics of vaccinia virus: demonstration of marker rescue

1 reference

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

7 January 2021

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

1 reference

7 January 2021

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

1 reference

7 January 2021

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

7 January 2021

Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters

1 reference

7 January 2021

Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

1 reference

7 January 2021

Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice

1 reference

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

7 January 2021

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

1 reference

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

7 January 2021

Hybrid vaccinia virus for mass hepatitis immunization?

1 reference

7 January 2021

Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations

1 reference

7 January 2021

The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice

1 reference

7 January 2021

Attenuated marmoset herpesvirus isolated from recombinants of virulent marmoset herpesvirus and hybrid plasmids

1 reference

7 January 2021

A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus

1 reference

7 January 2021

Deoxypyrimidine Kinases of Herpes Simplex Viruses Types 1 and 2: comparison of Serological and Structural Properties

1 reference

7 January 2021

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

1 reference

7 January 2021

[On the variation in "incubation time" of postvaccinal cerebral disease.]

1 reference

7 January 2021

The purification fo four strains of poxvirus

1 reference

7 January 2021

Identifiers

DOI

10.1038/317813A0

1 reference

16 December 2017

Dimensions Publication ID

1005453719

0 references

1 reference

16 December 2017